Effects of human plasma proteins on maturation of monocyte-derived dendritic cells

Immunology Letters

Volumn 100, Issue 2, 2005, Pages 113-119

  Tobiasova Czetoova Z ^a   Palmborg, A ^b   Lundqvist, A ^b   Karlsson, G ^c   Adamson, L ^b   Bartunkova J ^a   Masucci, G ^b   Pisa, P ^b  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Octapharma AB   (Sweden)

Author keywords

Dendritic cells; Maturation; Plasma proteins

Indexed keywords

C REACTIVE PROTEIN; CD83 ANTIGEN; CD86 ANTIGEN; DENDRITIC CELL VACCINE; FIBRINOGEN; FIBRONECTIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 4; PLASMINOGEN; POLYINOSINIC POLYCYTIDYLIC ACID; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN FUNCTION; ANTIGEN PRESENTING CELL; ARTICLE; BIOACCUMULATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DEVELOPMENTAL STAGE; ENDOCYTOSIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; LEUKOCYTE CULTURE; MELANOMA CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PURIFICATION;

ANTIGENS, CD; BLOOD PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRINOGEN; HUMANS; IMMUNOGLOBULINS; IMMUNOPHENOTYPING; LYMPHOCYTE CULTURE TEST, MIXED; MELANOMA; MEMBRANE GLYCOPROTEINS; MONOCYTES;

EID: 24344456706     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2005.03.009     Document Type: Article

References (36)

1. J. Banchereau, F. Briere, C. Caux, J. Davoust, S. Lebecque, and Y.J. Liu Immunobiology of dendritic cells Annu Rev Immunol 18 2000 767 811
2. P. Guermonprez, J. Valladeau, L. Zitvogel, C. Thery, and S. Amigorena Antigen presentation and T-cell stimulation by dendritic cells Annu Rev Immunol 20 2002 621 667
3. C. Rieser, G. Bock, H. Klocker, G. Bartsch, and M. Thurnher Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production J Exp Med 186 1997 1603 1608
4. L. Santambrogio, A.K. Sato, G.J. Carven, S.L. Belyanskaya, J.L. Strominger, and L.J. Stern Extracellular antigen processing and presentation by immature dendritic cells Proc Natl Acad Sci USA 96 1999 15056 15061
5. D. McIlroy, and M. Gregoire Optimizing dendritic cell-based anticancer immunotherapy: maturation state does have clinical impact Cancer Immunol Immunother 52 2003 583 591
6. M.B. Lutz, and G. Schuler Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 23 2002 445 449
7. H. Jonuleit, E. Schmitt, G. Schuler, J. Knop, and A.H. Enk Induction of interleukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells J Exp Med 192 2000 1213 1222
8. M. Menges, S. Rossner, C. Voigtlander, H. Schindler, N.A. Kukutsch, and C. Bogdan Repetitive injections of dendritic cells matured with tumor necrosis factor a induce antigen-specific protection of mice from autoimmunity J Exp Med 195 2002 15 21
9. J.N. Adkins, S.M. Varnum, K.J. Auberry, R.J. Moore, N.H. Angell, and R.D. Smith Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry Mol Cell Proteomics 1 2002 947 955
10. J. Gong, N. Nikrui, D. Chen, S. Koido, Z. Wu, and Y. Tanaka Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity J Immunol 165 2000 1705 1711
11. J. Galea-Lauri, D. Darling, G. Mufti, P. Harrison, and F. Farzaneh Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination Cancer Immunol Immunother 51 2002 299 310
12. A. Marten, T. Greten, C. Ziske, S. Renoth, B. Schottker, and P. Buttgereit Generation of activated and antigen-specific T cells with cytotoxic activity after co-culture with dendritic cells Cancer Immunol Immunother 51 2002 25 32
13. M. Sato, T. Takayama, H. Tanaka, J. Konishi, T. Suzuki, and T. Kaiga Generation of mature dendritic cells fully capable of T helper type 1 polarization using OK-432 combined with prostaglandin E2 Cancer Sci 94 2003 1091 1098
14. J. Bayry, S. Lacroix-Desmazes, C. Carbonneil, N. Misra, V. Donkova, and A. Pashov Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin Blood 101 2003 758 765
15. L.P.A. Adamson, A. Svensson, A. Lundqvist, M. Hansson, R. Kiessling, and G. Masucci Development of a technology platform for large-scale clinical grade production of dendritic cells Cytotherapy 6 2004 363 371
16. M. Kato, T.K. Neil, D.B. Fearnley, A.D. McLellan, S. Vuckovic, and D.N. Hart Expression of multilectin receptors and comparative FITC-dextran uptake by human dendritic cells Int Immunol 12 2000 1511 1519
17. F. Sallusto, M. Cella, C. Danieli, and A. Lanzavecchia Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products J Exp Med 182 1995 389 400
18. V. Cerundolo, I.F. Hermans, and M. Salio Dendritic cells: a journey from laboratory to clinic Nat Immunol 5 2004 7 10
19. A. Kaiser, N. Bercovici, J.P. Abastado, and A. Nardin Naive CD8+ T-cell recruitment and proliferation are dependent on stage of dendritic cell maturation Eur J Immunol 33 2003 162 171
20. H. Jonuleit, A. Giesecke-Tuettenberg, T. Tuting, B. Thurner-Schuler, T.B. Stuge, and L. Paragnik A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection Int J Cancer 93 2001 243 251
21. R.M. Steinman, and M. Dhodapkar Active immunization against cancer with dendritic cells: the near future Int J Cancer 94 2001 459 473
22. M.V. Dhodapkar, R.M. Steinman, J. Krasovsky, C. Munz, and N. Bhardwaj Antigen-specific inhibition of effector T-cell function in humans after injection of immature dendritic cells J Exp Med 193 2001 233 238
23. S. Paczesny, H. Ueno, J. Fay, J. Banchereau, and A.K. Palucka Dendritic cells as vectors for immunotherapy of cancer Semin Cancer Biol 13 2003 439 447
24. S.T. Smiley, J.A. King, and W.W. Hancock Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4 J Immunol 167 2001 2887 2894
25. R.G. Sitrin, P.M. Pan, S. Srikanth, and R.F. Todd III Fibrinogen activates NF-kB transcription factors in mononuclear phagocytes J Immunol 161 1998 1462 1470
26. S.T. Fan, and T.S. Edgington Integrin regulation of leukocyte inflammatory functions. CD11b/CD18 enhancement of the tumor necrosis factor-alpha responses of monocytes J Immunol 150 1993 2972 2980
27. Y. Okamura, M. Watari, E.S. Jerud, D.W. Young, S.T. Ishizaka, and J. Rose The extra domain A of fibronectin activates toll-like receptor 4 J Biol Chem 276 2001 10229 10233
28. S. Saito, N. Yamaji, K. Yasunaga, T. Saito, S. Matsumoto, and M. Katoh The fibronectin extra domain A activates matrix metalloproteinase gene expression by an interleukin-1-dependent mechanism J Biol Chem 274 1999 30756 30763
29. C.A. Swetman, Y. Leverrier, R. Garg, C.H. Gan, A.J. Ridley, and D.R. Katz Extension, retraction and contraction in the formation of a dendritic cell dendrite: distinct roles for Rho GTPases Eur J Immunol 32 2002 2074 2083
30. D. Burzyn, C.C. Jancic, S. Zittermann, M.I. Keller Sarmiento, L. Fainboim, and R.E. Rosenstein Decrease in cAMP levels modulates adhesion to fibronectin and immunostimulatory ability of human dendritic cells J Leukoc Biol 72 2002 93 100
31. A. Puig-Kroger, F. Sanz-Rodriguez, N. Longo, P. Sanchez-Mateos, L. Botella, and J. Teixido Maturation-dependent expression and function of the CD49d integrin on monocyte-derived human dendritic cells J Immunol 165 2000 4338 4345
32. J.S. Palumbo, K.E. Talmage, H. Liu, C.M. La Jeunesse, D.P. Witte, and J.L. Degen Plasminogen supports tumor growth through a fibrinogen-dependent mechanism linked to vascular patency Blood 102 2003 2819 2827
33. V.E. Woodhead, T.J. Stonehouse, M.H. Binks, K. Speidel, D.A. Fox, and A. Gaya Novel molecular mechanisms of dendritic cell-induced T-cell activation Int Immunol 12 2000 1051 1061
34. E. Ferrero, K. Vettoretto, A. Bondanza, A. Villa, M. Resnati, and A. Poggi uPA/uPAR system is active in immature dendritic cells derived from CD14+ CD34+ precursors and is downregulated upon maturation J Immunol 164 2000 712 718
35. A. Doni, G. Peri, M. Chieppa, P. Allavena, F. Pasqualini, and L. Vago Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells Eur J Immunol 33 2003 2886 2893
36. P. Rovere, G. Peri, F. Fazzini, B. Bottazzi, A. Doni, and A. Bondanza The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells Blood 96 2000 4300 4306